Erratum: Preeclampsia and risk of end stage kidney disease: A Swedish nationwide cohort study (PLoS Med (2019) 16(7): e1002875. doi. 10.1371/journal.pmed.1002875)

Research output: Contribution to journalComment/Debate

Abstract

In the Funding section, the following information was inadvertently omitted: Additional funding to KK from the Swedish Research Council grant no. 2018-00932. The full funding statement should read: The study was partly funded by the Irish Centre for Fetal and Neonatal Translational Research (INFANT) (grant no. 12/RC/2272), Strategic Research Programme in Diabetes at Karolinska Institutet (Swedish Research Council grant No 2009-1068), the Stockholm County Council (ALF), and the Swedish Kidney Foundation. Additional funding to KK from the Swedish Research Council grant no. 2018-00932. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Reference 1. Khashan AS, Evans M, Kublickas M, McCarthy FP, Kenny LC, Stenvinkel P, et al. (2019) Preeclampsia and risk of end stage kidney disease: A Swedish nationwide cohort study. PLoS Med 16(7): e1002875. https://doi.org/10.1371/journal.pmed.1002875 PMID: 31361741.

Original languageEnglish
Article numbere1002977
JournalPLOS Medicine
Volume16
Issue number10
DOIs
Publication statusPublished - 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Erratum: Preeclampsia and risk of end stage kidney disease: A Swedish nationwide cohort study (PLoS Med (2019) 16(7): e1002875. doi. 10.1371/journal.pmed.1002875)'. Together they form a unique fingerprint.

Cite this